Growth Metrics

Coeptis Therapeutics Holdings (COEPW) Operating Leases (2022 - 2025)

Historic Operating Leases for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to $29865.0.

  • Coeptis Therapeutics Holdings' Operating Leases fell 5797.75% to $29865.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $29865.0, marking a year-over-year decrease of 5797.75%. This contributed to the annual value of $61180.0 for FY2024, which is 3834.28% down from last year.
  • According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Operating Leases is $29865.0, which was down 5797.75% from $40612.0 recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Operating Leases registered a high of $99226.0 during Q4 2023, and its lowest value of $25480.0 during Q3 2023.
  • For the 4-year period, Coeptis Therapeutics Holdings' Operating Leases averaged around $52572.8, with its median value being $51065.0 (2025).
  • Its Operating Leases has fluctuated over the past 5 years, first surged by 17892.07% in 2024, then crashed by 5797.75% in 2025.
  • Over the past 4 years, Coeptis Therapeutics Holdings' Operating Leases (Quarter) stood at $56341.0 in 2022, then skyrocketed by 76.12% to $99226.0 in 2023, then crashed by 38.34% to $61180.0 in 2024, then plummeted by 51.19% to $29865.0 in 2025.
  • Its Operating Leases stands at $29865.0 for Q3 2025, versus $40612.0 for Q2 2025 and $51065.0 for Q1 2025.